In Stiff Person Syndrome, which is a rare autoimmune disease in the central nervous system with
autoantibodies targeting glutamic acid
decarboxylase (GAD65), the humoral autoimmune response was shown to consist of a Rituximab - sensitive part rapidly cleared after treatment, and a Rituximab - resistant part from long - lived and persistent plasma cells acting as a reservoir for secretion of
autoantibodies.